- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- November 2021
- 101 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Drug Pipelines
- April 2021
- 64 Pages
Global
€21199EUR$22,000USD£18,235GBP
- Report
- December 2022
- 162 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- August 2022
United States
From €1869EUR$1,940USD£1,608GBP
- Report
- August 2022
Global
From €1050EUR$1,090USD£903GBP
- Report
- August 2021
Global
From €3845EUR$3,990USD£3,307GBP
- Report
- August 2021
Europe
From €3295EUR$3,420USD£2,835GBP
- Report
- February 2021
Global
From €2852EUR$2,960USD£2,453GBP
- Report
- January 2023
- 90 Pages
Global
From €3368EUR$3,495USD£2,897GBP
- Clinical Trials
- August 2020
- 1620 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- March 2020
- 154 Pages
Global
From €10595EUR$10,995USD£9,113GBP
- Report
- December 2019
- 38 Pages
Global
From €3850EUR$3,995USD£3,311GBP
- Drug Pipelines
- October 2020
- 576 Pages
Global
From €1927EUR$2,000USD£1,658GBP
- Drug Pipelines
- December 2019
- 27 Pages
Global
From €3373EUR$3,500USD£2,901GBP
- Report
- April 2019
- 71 Pages
Global
From €6740EUR$6,995USD£5,798GBP
- Report
- May 2023
- 79 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- May 2023
- 109 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- August 2021
- 73 Pages
Global
From €3200EUR$3,557USD£2,849GBP
- Report
- August 2022
- 541 Pages
Global
From €2409EUR$2,500USD£2,072GBP
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more